Increases in drug prices are of concern to worldwide health systems

By Danélia Botes

March 17, 2023

In surveys of ISPOR members, drug pricing was revealed to be a major concern, and one of the top 10 health economics and outcomes research issues influencing the availability of innovative treatments and healthcare decisions.

Despite the fascinating ways that different research studies proposed to understand the puzzle of drug pricing, it is evident that drug prices must factor in the research uncertainties and other costs in addition to the cost of clinical trials and production and should be set to yield an acceptable return on investment.

There has been a lot of discussion about the fairness of drug pricing. The concept is multifaceted, and when discussing it, drug characteristics and market forces must be included. This conversation is further complicated by the lack of transparency in drug pricing and the rise in drug prices.

It is likely that the debate will persist.

Reference url

Recent Posts

Pharmacogenetic Screening
            

Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depressive Disorder

🔍 Discover the cost-effectiveness of pharmacogenetic screening in treating Major Depressive Disorder (MDD).
This approach could save costs and improve patient outcomes in the Spanish National Health System. Read more to understand the potential benefits and future implications. 🌐💡
#SyenzaNews #Pharmacogenetics #MajorDepression #CostEffectiveness #HealthcareInnovation

                 

Healthy Ageing Index and Assessment of Age-Related Outcomes

🌟 Healthy Ageing Index and Assessment of Age-Related Outcomes 🌟

📊 Unlocking the Secrets of Healthy Ageing in Singapore! Discover the significance of the Healthy Ageing Index (HAI) in predicting age-related outcomes! Learn how this tool can help promote healthy ageing and improve quality of life. 👵👴

#SyenzaNews #HealthyAgeing #SingaporeHealthcare #AgeingPopulation #HealthOutcomes

Thailand's healthcare system
              

Thailand’s Healthcare System and the Role of HTA: A Model of Universal Health Coverage

Thailand’s healthcare system is a beacon of efficiency and effectiveness. Achieving Universal Health Coverage in 2002, the country has made remarkable strides in health outcomes, despite spending less compared to other upper-middle-income countries.

Learn how Thailand’s use of Health Technology Assessment (HTA) has played a crucial role in this success and the future steps to address current challenges. 🌍💉

#SyenzaNews #Healthcare #UniversalHealthCoverage #HTA #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.